The Martindale: The Complete Drug Reference
| Author | : | |
| Rating | : | 4.25 (845 Votes) |
| Asin | : | 0857113097 |
| Format Type | : | paperback |
| Number of Pages | : | 2 Pages |
| Publish Date | : | 2014-12-02 |
| Language | : | English |
DESCRIPTION:
Privatized from HMSO in 1996, TSO has a 200-year inheritance of secure, no-fail delivery to Her Majesty's Government and Parliament and it is the largest publisher in the UK by volume, publishing over 15,000 titles a year.
. About the Author Privatized from HMSO in 1996, TSO has a 200-year inheritance of secure, no-fail delivery to Her Majesty's Government and Parliament and it is the largest publisher in the UK by volume, publishing over 15,000 titles a year
Based on published information and extensively referencedInternationaladoption: Recognised and adopted worldwideIn two hardback volumes, Martindale contains:Over 6,300 drug monographs (and over 7,500 online, accessible via a subscription to MedicinesComplete)Over 185,000 preparations (and over 270,000 online, via MedicinesComplete)Over 54,000 reference citationsOver 20,000 (and 28,000 online, via MedicinesComplete) manufacturers and distributorsProprietary preparations from 43 countries and regionsNearly 700 treatment reviews, with references from the published literatureInformation to help you identify medicines, the local equivalent and the manufacturerHerbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicinesImprovements for the 39th edition include:Over 130 new monographs, including:Lumacaftor:a cystic fibrosis transmembrane conductance regulator (CFTR) protein correctorPitolisant: a central stimulant used in the treatment of narcolepsyRolapitant: a neurokinin-1 receptor antagonist that is used for the prevention of nausea and vomiting associated with cancer chemotherapyUmeclidinium Bromide: a quaternary ammonium antimuscarinic used as a bronchodilator in the treatment of reversible airways obstructionNew Hepatitis C treatment table and drugs including ledipasvir, ombitasvir, paritaprevir, and dasabuvirCoverage of proprietary preparations in 43 countries incl